ESSA Pharma to Present at Upcoming March Investor Conferences
ESSA Pharma Inc. (NASDAQ: EPIX) announced that President and CEO Dr. David R. Parkinson will present at three virtual investor conferences in March 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma Inc. (NASDAQ: EPIX) announced that President and CEO Dr. David R. Parkinson will present at three virtual investor conferences in March 2021. The conferences include the Cowen 41st Annual Health Care Conference on March 4 at 12:10 p.m. ET, the H.C. Wainwright Annual Global Life Sciences Conference on March 9 at 7:00 a.m. ET, and the Oppenheimer 31st Annual Healthcare Conference on March 18 at 11:20 a.m. ET. Webcasts will be accessible on the ESSA website and archived for 90 days after each event.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was +6.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOUSTON, Texas and VANCOUVER, Canada, Feb. 25, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at three upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be available for one-on-one meetings.
Presentation Details:
Event: Cowen 41st Annual Health Care Conference
Date: Thursday, March 4, 2021
Time: 12:10 p.m. ET
Event: H.C. Wainwright Annual Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time (on-demand): 7:00 a.m. ET
Event: Oppenheimer 31st Annual Healthcare Conference
Date: Thursday, March 18, 2021
Time: 11:20 a.m. ET
Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
View original content:http://www.prnewswire.com/news-releases/essa-pharma-to-present-at-upcoming-march-investor-conferences-301235830.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.